Table of Contents:

Chapter 1.     Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy

Chapter 2.     Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy

Chapter 3.     Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy

Chapter 4.     Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy

Chapter 5.     Hypertrophic Cardiomyopathy with Latent (Provacable) Obstruction:  Pathophysiology and Management

Chapter 6.     Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Chapter 7.     Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy

Chapter 8.     Disturbed Vascular Control in Hypertrophic Cardiomyopathy:  Mechanisms and Clinical Significance

Chapter 9.     Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions

Chapter 10.   Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy

Chapter 11.   Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy

Chapter 12.   Hypertrophic Cardiomyopathy in Japan:  Clinical, Morphologic and Genetic Expression

Chapter 13.   Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy

Chapter 14.   Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy

Chapter 15.   Obstructive Hypertrophic Cardiomyopathy:  Results of Septal Myectomy

Chapter 16.   United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy

Chapter 17.   Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy

Chapter 18.   Alcohol Septal Ablation

Chapter 19.   Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy:  A Seven-Year Experience

Chapter 20.   Role of Septal Ablation in a Surgical Center

Chapter 21.   Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy

Chapter 22.   Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy:  Extreme Left Ventricular Hypertrophy as a New Indicator of Risk

Chapter 23.   Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy

Chapter 24.   Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete:  An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias

Chapter 25.   The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies

Chapter 26.   Importance of Congenital Coronary Artery Anomalies

Chapter 27.   Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy:  Identification with the Italian Preparticipation  Athlete Screening Program

Chapter 28.   Cardiovascular Causes of Sudden Death, Preparticipation Screening, and Criteria for Disqualification in Young Athletes

Chapter 29.   Sudden Death Due to Chest Blows (Commotio Cordis)

Chapter 30.   Naturally Occurring Animal Models of Cardiovascular Disease Causing Premature Death

Chapter 31.   The Role of the Internet and Patient Support Groups for Those Living with Hypertrophic Cardiomyopathy

Also available under $40: Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians